11/8/26 Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity Previous Retention by Design - Keeping Families Engaged for Multi-Year Studies Next Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale You Might Also Like Designing Neuromuscular Trials for Successful Execution: The Role of Specialized CROs, Sites and Clinical Research Vendors Leveraging Natural History and RWE for Rare Approvals Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Write Your Own Endpoint Justification Retention by Design - Keeping Families Engaged for Multi-Year Studies
11/8/26 Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity Previous Retention by Design - Keeping Families Engaged for Multi-Year Studies Next Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale You Might Also Like Designing Neuromuscular Trials for Successful Execution: The Role of Specialized CROs, Sites and Clinical Research Vendors Leveraging Natural History and RWE for Rare Approvals Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Write Your Own Endpoint Justification Retention by Design - Keeping Families Engaged for Multi-Year Studies
